Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
Phase
2Span
312 weeksSponsor
Goethe UniversityGoch
Recruiting
Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagnosed AML and Intermediate- or Adverse Genetics
Phase
3Span
408 weeksSponsor
University of UlmGoch
Recruiting
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project
Phase
N/ASpan
1800 weeksSponsor
University of UlmGoch
Recruiting
Goch
Recruiting
Healthy Volunteers
1-4 of 4